PHARMATHER
PharmaTher Holdings Ltd is a clinical-stage biotech company focused on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders.
PHARMATHER
Industry:
Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.pharmather.com
Status:
Active
Contact:
1-888-846-3171
Email Addresses:
[email protected]
Total Funding:
10 M CAD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Apache Global Site Tag
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.pharmather.com Semrush global rank: 5.67 M Semrush visits lastest month: 1.48 K
- Host name: pages-custom-29.weebly.com
- IP address: 199.34.228.77
- Location: San Francisco United States
- Latitude: 37.7642
- Longitude: -122.3993
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94107
More informations about "PharmaTher"
About PharmaTher Ketamine - PharmaTher Holdings Ltd. Ketamine
PharmaTher owns 49% of Sairiyo Therapeutics Inc., which focuses on advancing the clinical development of an improved and patented enteric-coated orally bioavailable formulation of …See details»
PharmaTher Holdings Ltd. Ketamine - Ketamine psychedelic …
PharmaTher Holdings Ltd. 82 Richmond Street East Toronto, Ontario Canada M5C 1P1See details»
PharmaTher - Crunchbase Company Profile & Funding
PharmaTher has developed a hydrogel-forming microneedle patch for delivering Ketamine, targeting treatment for neuropsychiatric, neurodegenerative, and pain disorders. PD-001 A …See details»
PharmaTher - Psychedelic Science Review
PharmaTher. PharmaTher is a clinical stage biotechnology company based in Toronto. Founded in 2019, PharmaTher works on research, development, and commercialization of new …See details»
Pharmather, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Pharmather, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 42 news, and 1 literature, Disease Domain:Nervous System Diseases, Immune System …See details»
PharmaTher Holdings - Overview, News & Similar companies
Jun 20, 2023 Who is PharmaTher Holdings. PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is a clinical-stage psychedelics biotech company focused on the research, …See details»
PharmaTher Holdings - PitchBook
PharmaTher Holdings General Information Description. PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic …See details»
PharmaTher | VentureRadar
PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), is a specialty life sciences company focused on the research and …See details»
Company PharmaTher Holdings Ltd. - MarketScreener.com
Dec 31, 2019 PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing …See details»
Pharmather Holdings Ltd Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Pharmather Holdings Ltd of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
PharmaTher Holdings Company Description - Stock Analysis
Dec 6, 2024 PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery …See details»
Pharmather Inc. | Psychedelic Invest
Pharmather is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals. The company was founded with a particular focus on …See details»
PharmaTher Holdings - Craft
Feb 2, 2023 PharmaTher Holdings is a biotech company focused on the research, development, and commercialization of novel uses and pain disorders. It offers focused on the research, …See details»
PharmaTher Holdings Ltd. - Canadian Securities Exchange
PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company focused on the research, development and commercialization of ketamine and novel microneedle patches for …See details»
Press Releases Ketamine - PharmaTher Holdings Ltd. Ketamine
PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM), is a specialty life sciences company focused on the research and development of psychedelic …See details»
Pharmather Holdings Ltd, PHRRF:QBB profile - FT.com
Nov 27, 2024 PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing …See details»
PharmaTher Holdings Provides Corporate Update - Yahoo Finance
PharmaTher’s priority is to commercialize KETARX™ under ketamine’s FDA-approved label. The Company expects to market various dosage forms of KETARX™, such as 10 mg/ml, 50 mg/ml …See details»
Press Releases Ketamine - PharmaTher Holdings Ltd. Ketamine
TORONTO, October 19, 2021 -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, announces …See details»
PharmaTher Holdings Ltd. (PHRM.CN) - Yahoo Finance Canada
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to …See details»
Press Releases Ketamine - PharmaTher Holdings Ltd. Ketamine
PharmaTher has entered into an agreement with Alcami Corporation, a global pharmaceutical contract development and manufacturing organization with extensive experience in cGMP …See details»